REGENXBIO Earnings
NASDAQ: RGNXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.07-0.02 (-0.25%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.36
REGENXBIO earnings summary
REGENXBIO is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-1.36.
Summary generated from market data by MetaCap's automated system. Methodology